144 related articles for article (PubMed ID: 12189534)
21. Graft-versus-host disease following allogeneic bone marrow transplantation.
Yoshikawa S; Akao Y; Hiraiwa A; Sao H; Yamauchi T; Tahara T; Yoshikawa H; Matsuyama K; Kimura S; Kitayama S
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():509-18. PubMed ID: 6394814
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine metabolite pattern in blood from patients with acute GVHD after BMT.
Christians U; Spiekermann K; Bader A; Schottmann R; Linck A; Wonigeit K; Sewing KF; Link H
Bone Marrow Transplant; 1993 Jul; 12(1):27-33. PubMed ID: 8374534
[TBL] [Abstract][Full Text] [Related]
23. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.
Jantunen E; Ruutu P; Niskanen L; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T
Bone Marrow Transplant; 1997 Apr; 19(8):801-8. PubMed ID: 9134172
[TBL] [Abstract][Full Text] [Related]
24. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb HJ
Bone Marrow Transplant; 1996 Jun; 17(6):1105-11. PubMed ID: 8807122
[TBL] [Abstract][Full Text] [Related]
25. Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy.
Roy J; McGlave PB; Filipovich AH; Miller WJ; Blazar BR; Ramsay NK; Kersey JH; Weisdorf DJ
Bone Marrow Transplant; 1992 Jul; 10(1):77-82. PubMed ID: 1515883
[TBL] [Abstract][Full Text] [Related]
26. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Kanamaru A; Takemoto Y; Kakishita E; Dohy H; Kodera Y; Moriyama Y; Shibata A; Kasai M; Katoh S; Saitoh H
Bone Marrow Transplant; 1995 Jun; 15(6):885-9. PubMed ID: 7581086
[TBL] [Abstract][Full Text] [Related]
27. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients.
Wingard JR; Nash RA; Ratanatharathorn V; Fay JW; Klein JL; Przepiorka D; Maher RM; Devine SM; Boswell G; Bekersky I; Fitzsimmons W
Bone Marrow Transplant; 1997 Jul; 20(1):49-51. PubMed ID: 9232256
[TBL] [Abstract][Full Text] [Related]
28. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
[TBL] [Abstract][Full Text] [Related]
29. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
30. Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Weaver CH; Clift RA; Deeg HJ; Storb R; Appelbaum FR; Bensinger W; Doney K; Hansen JA; Martin PO; Sanders J
Bone Marrow Transplant; 1994 Dec; 14(6):885-93. PubMed ID: 7711667
[TBL] [Abstract][Full Text] [Related]
31. [Control of graft-versus-host disease and infection associated with immunosuppression].
Teshima H; Masaoka T
Rinsho Ketsueki; 1991 Apr; 32(4):376-80. PubMed ID: 1906115
[TBL] [Abstract][Full Text] [Related]
32. Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
Chao NJ; Parker PM; Niland JC; Wong RM; Dagis A; Long GD; Nademanee AP; Negrin RS; Snyder DS; Hu WW; Gould KA; Tierney DK; Zwingenberger K; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1996 May; 2(2):86-92. PubMed ID: 9118303
[TBL] [Abstract][Full Text] [Related]
33. [How long should cyclosporin be administered following bone marrow transplantation?].
Gratwohl A; Tichelli A; Stauffer G; Passweg J; Pless M; Gengenbacher D; Buser U; Signer E; Haberthür C; Gimmi C
Schweiz Med Wochenschr; 1994 Jan; 124(1-2):44-50. PubMed ID: 8296190
[TBL] [Abstract][Full Text] [Related]
34. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment.
Yuen KY; Woo PC; Hui CH; Luk WK; Chen FE; Lie AK; Liang R
Bone Marrow Transplant; 1998 Jun; 21(11):1137-43. PubMed ID: 9645577
[TBL] [Abstract][Full Text] [Related]
35. Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants.
Abraham R; Szer J; Bardy P; Grigg A
Bone Marrow Transplant; 1997 Nov; 20(9):773-7. PubMed ID: 9384480
[TBL] [Abstract][Full Text] [Related]
36. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.
Anderson PM; Ramsay NK; Shu XO; Rydholm N; Rogosheske J; Nicklow R; Weisdorf DJ; Skubitz KM
Bone Marrow Transplant; 1998 Aug; 22(4):339-44. PubMed ID: 9722068
[TBL] [Abstract][Full Text] [Related]
37. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Hiller E
Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
[TBL] [Abstract][Full Text] [Related]
38. Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels.
Imamura M; Hashino S; Kobayashi S; Kobayashi H; Tanaka J; Imai K; Kasai M; Sakurada K; Miyazaki T
Int J Hematol; 1994 Jul; 60(1):85-9. PubMed ID: 7919241
[TBL] [Abstract][Full Text] [Related]
39. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Nash RA; Pepe MS; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum FR; Bowden RA; Deeg HJ; Doney K
Blood; 1992 Oct; 80(7):1838-45. PubMed ID: 1391947
[TBL] [Abstract][Full Text] [Related]
40. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Van Lint MT; Uderzo C; Locasciulli A; Majolino I; Scimé R; Locatelli F; Giorgiani G; Arcese W; Iori AP; Falda M; Bosi A; Miniero R; Alessandrino P; Dini G; Rotoli B; Bacigalupo A
Blood; 1998 Oct; 92(7):2288-93. PubMed ID: 9746766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
